In epithelial ovarian cancer, the expression of GAS5 is lower than that in the adjacent tissues, and GAS5 inhibits DDP resistance and tumor progression of epithelial ovarian cancer via the GAS5-E2F4-PARP1-mitogen-activated protein kinase (MAPK) axis.113. This evidence concerns the gene WNK2 and ovarian carcinoma.